Prestigious Osteosarcoma Expert Joins the Children’s Cancer Hospital
CCH Newsletter - Fall 2010
World-renowned sarcoma specialist Najat Daw, M.D., joined the Children’s Cancer Hospital in August as professor of pediatrics. Bringing a wealth of experience, she will oversee the treatment of pediatric sarcoma patients at
MD Anderson as part of the hospital’s new Virtual Osteosarcoma and Ewing’s Sarcoma Center.
Daw brings a research background focused on the clinical characteristics, treatment and outcome of osteosarcoma, as well as the development of new agents for pediatric cancers, to MD Anderson. She began her career with a medical degree from the American University of Beirut in Lebanon, but moved to the United States to complete her residency in pediatrics at Baylor College of Medicine in Houston. In 1993, Daw began her postdoctoral fellowship in pediatric hematology/oncology at St. Jude Children’s Research Hospital in Memphis, Tenn., and became a full-time faculty member at St. Jude in 1996.
Since that time, Daw has dedicated her career to opening frontline clinical trials for newly diagnosed sarcoma patients. She is a member of the Children’s Oncology Group’s Developmental Therapeutics Committee, and led an international collaboration with a referral center in Chile to enhance accrual of clinical trials.
“The recruitment of Dr. Daw is crucial to the mission of the Children’s Cancer Hospital as we work to improve the survival rate of children with bone cancers,” says Eugenie Kleinerman, M.D., head of the Children’s Cancer Hospital. “Her clinical expertise and devotion to translational research are coupled with her outstanding compassion for children with cancer. We’re excited to have her on our team.”
- Pediatric Osteosarcoma
- Children's Cancer Hospital